GSK Smoking Cessation Business Returns To Positive Growth In Q3
This article was originally published in The Tan Sheet
Executive Summary
Sales gains in GlaxoSmithKline's smoking cessation franchise - the first in over a year - helped the firm's OTC drug segment and overall consumer business to a single-digit sales increase in the third quarter.